Increased expression of SLC38A2 in natural killer cells promotes anti-tumor immunity
	    		
		   		
		   			
		   		
	    	
    	 
    	10.3781/j.issn.1000-7431.2023.2303-0097
   		
        
        	
        		- VernacularTitle:氨基酸转运蛋白SLC38A2促进NK细胞对肿瘤细胞的杀伤作用
 
        	
        	
        	
        		- Author:
	        		
		        		
		        		
			        		Hancao YANG
			        		
			        		
			        		
			        			1
			        			
			        		
			        		
			        		
			        		
			        		;
		        		
		        		
		        		
			        		Jian GAO
			        		
			        		;
		        		
		        		
		        		
			        		Dan ZHAO
			        		
			        		;
		        		
		        		
		        		
			        		Qian LI
			        		
			        		;
		        		
		        		
		        		
			        		Jin LI
			        		
			        		;
		        		
		        		
		        		
			        		Hong TU
			        		
			        		;
		        		
		        		
		        		
			        		Yu GAN
			        		
			        		
		        		
		        		
		        		
		        		
		        			
			        		
			        		Author Information
			        		
		        		
		        		
			        		
			        		
			        			1. 上海交通大学医学院附属仁济医院,上海市肿瘤研究所肿瘤系统医学全国重点实验室,上海 200032
			        		
		        		
	        		
        		 
        	
        	
        	
        	
        		- Keywords:
        			
	        			
	        				
	        				
			        		
				        		Natural killer cells;
			        		
			        		
			        		
				        		Amino acid transporter;
			        		
			        		
			        		
				        		SLC38A2;
			        		
			        		
			        		
				        		Tumor cells
			        		
			        		
	        			
        			
        		
 
        	
            
            
            	- From:
	            		
	            			Tumor
	            		
	            		 2023;43(11):854-865
	            	
            	
 
            
            
            	- CountryChina
 
            
            
            	- Language:Chinese
 
            
            
            	- 
		        	Abstract:
			       	
			       		
				        
				        	Objective:To investigate the effect of solute carrier family 38 member 2(SLC38A2)on the cytotoxicity of natural killer(NK)cells against tumor cells. Methods:Real-time fluorescence quantitative PCR was used to detect the mRNA expression of different glutamine transporters(SLC38A2,SLC1A5,SLC7A5,SLC7A1 and SLC1A4)in natural killer(NK)cells under glutamine deficiency or the spleens of dieting mice.NK-92MI cells were infected with the recombinant lentivirus carrying SLC38A2 gene to construct SLC38A2-overexpressing NK cells.After SLC38A2 overexpression or increasing glutamine concentration,the lactate dehydrogenase releasing assay was used to detect the cytotoxicity of NK cells against pancreatic tumor cell PANC-1 and liver cancer cell HUH-7,and the apoptosis of two tumor cells was detected by flow cytometry assay after AnnexinV/7-AAD staining.Finally,the expression level of cell surface CD107a,a degranulation marker,as well as the expression of cytotoxic effectors interferon-γ(IFN-γ)and tumor necrosis factor-α(TNF-α),in NK cells was further investigated by flow cytometry. Results:The mRNA expression of glutamine transporter SLC38A2 was significantly upregulated in NK cells under glutamine deficient conditions and the spleens of dieting mice(P<0.001,P<0.01).SLC38A2-overexpressing NK-92MI cell model were successfully established.Overe-xpression of SLC38A2 or glutamine treatment could significantly increase the cytotoxicity of NK-92MI cells against pancreatic tumor cell PANC-1 and liver cancer cell HUH-7(P<0.05)and obviously promote the apoptosis of tumor cells(P<0.01).Flow cytometry analysis results showed that SLC38A2-overexpressing NK-92MI cells significantly increased CD1 07a expression on the cell surface and produced more IFN-γ and TNF-α when co-cultured with tumor cells(P<0.001). Conclusion:The amino acid transporter SLC38A2 can significantly enhance the cytotoxicity of NK cells against tumor cells.